Corona Virus disease (COVID19) in Very Elderly
Intensive care Patients (VIPs)
A multinational, multicenter study of outcomes and prognostic factors in coronavirus disease (COVID-19) in very old intensive care patients.
The coronavirus SARS-CoV-2 is currently affecting thousands of patients across many countries and there is an urgent need to investigate patient characteristics and outcome trajectories.
The VIP network which has previously (2016-2019) conducted the most extensive prospective studies (VIP1, VIP2) on elderly ICU patients, has immediately deployed this study of elderly COVID19 patients starting now.
You will receive an further information when you register.
See the COVIP page for information, protocol, documents, notes and ethical approval etc.
The first VIP2 publication has been published in Intensive Care Medicine (freely available):
The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive care medicine, 10.1007/s00134-019-05853-1.